ENDRA Life Sciences

ENDRA Life Sciences, based in Ann Arbor, Michigan, is a biotechnology company focused on developing innovative medical imaging technology. Their core product leverages the thermoacoustic effect to enhance the sensitivity and specificity of clinical ultrasound, particularly for measuring liver fat. This technology aims to address Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), conditions affecting over a billion people worldwide.

ENDRA Life Sciences has made significant strides in the medical imaging field, contributing to early detection and management of liver diseases. Their thermoacoustic technology represents a breakthrough in non-invasive diagnostics, potentially reducing the need for more invasive procedures like biopsies. The company's global reach and innovative approach have positioned it as a key player in the biotech industry, driving advancements in healthcare diagnostics.